MedTrace Logo

Neurobehavioral Moderators of Post-traumatic Disease Trajectories

NCT03756545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2020-03-13

No results posted yet for this study

Summary

The research goal is to uncover the neurocognitive moderators of PTSD trajectories, by documenting clinical symptoms, cognitive functioning, and brain structure and function, one-, six- and fourteen months following a traumatic event, in a large population of survivors at initial high risk for PTSD.

Conditions

Sponsors & Collaborators

  • New York University

    collaborator OTHER

  • Texas A&M University

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Arieh Y Shalev, Prof. · Department of Psychiatry, NYU Langone Medical Center, New York, NY, United States

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-20
Primary Completion
2020-03-11
Completion
2020-03-11

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03756545 on ClinicalTrials.gov